Hyperlipidemia After Renal Transplantation And Its Relation To Graft And Patient Survival
Trauma Monthly: 10 (2); 129-134 Article Type: Research Article
B, Ahmadzad Asi
V, et al. Hyperlipidemia After Renal Transplantation And Its Relation To Graft And Patient Survival ,
Online ahead of Print
Objectives: The aim of this study is to evaluate the incidence of hyperlipidemia after RT. Materials and Methods: We studied 687 RT recipients in a cross-sectional design to determine the frequency of hypercholestrinemia and hypertriglyceridemia before and one month to one year after renal transplantation and its relation to patient and graft prognosis in two medical centers in Iran from 1988-2004. Cyclosporine was the constant part of immunosuppressive treatment in all study subjects. Results: One and five-year graft survival time was 94.23% and 81.34% respectively. The prevalence of hypercholestrinemia after transplantation was 59.9% among patients. Mean (±2SE) serum cholesterol levels before and after transplantation were 161.15±3.81 and 213.83±4.53 mg/dl respectively, (p<0.001), and 159.99±13.08 and 196.28±19.6 mg/dl respectively for triglyceride levels. There was no significant correlation between dose of CsA, graft and patient survival time and severity of hyperlipidemia (determined by cholesterol and triglycerid levels) in the study. Conclusions: Lipids metabolism abnormalities found in this study were similar to other studies but we could not specify a relation with patient or graft survival. In addition, there maybe a different rout for development of hyperlipidemia with adverse effect of immunosuppressive drugs in our study samples.
© 0, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.